Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simcyp-guided Warfarin Dosing in Cirrhotic Patients with Portal Vein Thrombosis
NCT07571460Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of warfarin in portal vein thrombosis (PVT) (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Time to Achieve Therapeutic INR up to 14 days. Started Mar 2024; status: completed.
02
Drugs
warfarin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT07571460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07571460.